EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma extrachromosomal circular DNA as a biomarker in EGFR ‐targeted therapy of non‐small cell lung cancer

Simone Stensgaard iD, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S Sorensen iD

Molecular Oncology · 2026-04 · 20 (4) · 1061-1073

DOI: 10.1002/1878-0261.70138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 30.10.2025. Verfasst von Simone Stensgaard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Aarhus University Hospital, Denmark. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Biomarkers, Tumor, DNA, Circular. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEYE Foundation, Kræftens Bekæmpelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The genomic instability associated with cancer can result in the formation of extrachromosomal circular DNA (eccDNA), which contributes to tumor heterogeneity, gene amplification, tumor evolution, and drug resistance. However, most studies on eccDNA have been conducted on tumor tissue or cancer cell lines, and limited research has been done on eccDNA in plasma. In this study, we investigated eccDNA in non‐small cell lung cancer (NSCLC) by sequencing plasma eccDNA from 32 epidermal growth factor receptor ( EGFR )‐mutated NSCLC patients before and during treatment with osimertinib, as well as plasma eccDNA from five healthy individuals. Plasma eccDNA was identified in all samples but with significantly higher levels in cancer patients than healthy controls. EGFR ‐overlapping eccDNA, eccDNA that contains part of or the whole EGFR gene, was detected in the majority of samples both at baseline and during treatment. High levels of EGFR ‐overlapping eccDNA during osimertinib treatment were associated with significantly shorter progression‐free survival and overall survival. Plasma eccDNA represents a newly identified type of biomarker for monitoring treatment efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsBiomarkers, TumorDNA, CircularMolecular Targeted TherapyHumansErbB ReceptorsMaleFemaleMiddle AgedAgedAniline CompoundsAcrylamidesMutationIndolesPyrimidines

Stichwörter der Autor:innen

EGFR‐TKIcancer biomarkersextrachromosomal circular DNAliquid biopsylung cancer

Substanzen

ErbB ReceptorsBiomarkers, TumorDNA, CircularEGFR protein, humanosimertinibAniline CompoundsAcrylamidesIndolesPyrimidines

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, Aarhus University Hospital, Denmark.
  • Department of Clinical Medicine, Aarhus University, Denmark.
  • Department of Genetics, University of Alabama at Birmingham, Alabama, USA.
  • Department of Oncology, Aarhus University Hospital, Denmark.

ORCID-Profile: Simone Stensgaard, Boe S Sorensen

Förderung

  • NEYE Foundation
  • Kræftens Bekæmpelse

Zitieren

APA

Stensgaard, S., Mehmood, S., Ebert, E. B. F., Meldgaard, P., Dutta, A., & Sorensen, B. S. (2026). Plasma extrachromosomal circular DNA as a biomarker in EGFR ‐targeted therapy of non‐small cell lung cancer. Molecular Oncology, 20(4), 1061-1073. https://doi.org/10.1002/1878-0261.70138

Vancouver

Stensgaard S, Mehmood S, Ebert EBF, Meldgaard P, Dutta A, Sorensen BS. Plasma extrachromosomal circular DNA as a biomarker in EGFR ‐targeted therapy of non‐small cell lung cancer. Molecular Oncology. 2026;20(4):1061-1073. doi:10.1002/1878-0261.70138

BibTeX
@article{Stensgaard2026,
  author = {Stensgaard, Simone and Mehmood, Sarmad and Ebert, Eva Boysen Fynboe and Meldgaard, Peter and Dutta, Anindya and Sorensen, Boe S},
  title = {Plasma extrachromosomal circular DNA as a biomarker in EGFR ‐targeted therapy of non‐small cell lung cancer},
  journal = {Molecular Oncology},
  year = {2026},
  volume = {20},
  number = {4},
  pages = {1061--1073},
  doi = {10.1002/1878-0261.70138}
}
Kostenlos starten →